Inspire Medical Systems (NYSE:INSP) announced today that the FDA approved an expanded indication for its sleep apnea therapy. Minneapolis-based Inspire develops minimally invasive solutions for patients with obstructive sleep apnea (OSA). The proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that treats moderate to severe OSA. It offers an alternative to traditional […]
Inspire Medical Systems Inc.
Inspire Medical grows sales 84% in Q1, raises full-year guidance
Inspire Medical Systems (NYSE:INSP) this week posted first-quarter results that beat the overall consensus on Wall Street. The Minneapolis-based implantable sleep therapy device company reported profit losses of $15.4 million, or 53¢ per share, on sales of $127.9 million for the three months ended March 31, for a sales growth of 84.34% compared to Q1 […]
FDA OKs Inspire therapy for younger Down syndrome patients
Inspire Medical Systems (NYSE:INSP) announced today that the FDA has approved its implantable Inspire therapy for pediatric Down syndrome patients. “Since our first FDA approval in 2014, the research team at Mass Eye and Ear [Boston], led by Dr. Christopher Hartnick, have pioneered the use of Inspire in this important group of people, and we […]
Inspire Medical stock rises on massive Q4 EPS beat
Inspire Medical Systems (NYSE:INSP) shares ticked up today on fourth-quarter results that came in well ahead of the consensus forecast. Shares of INSP were up more than 7% at $268.22 apiece in morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose more than 13%. […]
Axonics, Outset lead medtech space on Deloitte’s list of fastest growing companies
Deloitte today released its “North America Technology Fast 500” list of growing companies, including a handful of medtech firms. The list, which ranking of the fastest-growing North American companies across a range of sectors, included several “Life Sciences” outfits. Immunology company Vir Biotechnology led the way in first place on the list. Axonics (Nasdaq:AXNX) represented […]
Inspire Medical Systems raises guidance on 77% sales growth in Q3
Inspire Medical Systems (NYSE:INSP) today posted third-quarter results that beat the overall consensus on Wall Street and raised its full-year guidance. The Minneapolis-based sleep apnea treatment device company reported losses of $16.8 million, or -60¢ per share, on sales of $109.2 million for the three months ended Sept. 30, for a sales growth of 77.01% […]
10 big earnings stories from the last quarter: How are medtech stocks doing now?
Economic uncertainty appears to have produced a wide variety of medtech earnings stories during the most recent round of quarterly results. Some medical device companies received massive boosts from their quarterly performance, while others saw their stocks sink amid missed projections and other various issues. The phrase “macroeconomic headwinds” was a common phrase. Medtech faces […]
Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
Inspire Medical Systems (NYSE: INSP) today announced it appointed Ezgi Yagci as VP of investor relations, effective immediately. Yagci joins the company from Zimmer Biomet, where she was the investor relations manager since July 2020. She was responsible for all aspects of earnings preparation, investment conference participation, sell-side interactions and targeted, proactive shareholder outreach and […]
Inspire Medical Systems revenue up 71% in Q2
Inspire Medical Systems (NYSE: INSP) easily blew past Wall Street predictions in Q2, though the company is scaling back its gross margin projections. Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable, pacemaker-like device that uses neurostimulation to treat obstructive sleep apnea. It announced yesterday evening that it lost $14.5 million, or 53¢ per […]
Inspire Medical appoints new independent board directors
Inspire Medical Systems (NYSE:INSP) announced today that it appointed Cynthia Burks and Dr. Charisse Sparks as board directors. The appointment of Burks and Sparks as independent directors to the board of the minimally invasive sleep apnea treatment developer was made effective on July 28, 2022. Burks previously served as chief human resources officer for Genentech […]
FDA approves expanded, full-body MRI compatibility with Inspire therapy
Inspire Medical Systems recently announced that FDA has approved additional MRI scan conditions for use with Inspire therapy Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable device that uses neurostimulation to treat obstructive sleep apnea. Company officials in a July 6 news release said the full-body MRI approval expands the Inspire use labeling. […]
